Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
about
Antihistaminic, anti-inflammatory, and antiallergic properties of the nonsedating second-generation antihistamine desloratadine: a review of the evidenceARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycleReview of Desloratadine Data Using the ARIA Guidelines.Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial.A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress.A direct comparison of efficacy between desloratadine and rupatadine in seasonal allergic rhinoconjunctivitis: a randomized, double-blind, placebo-controlled studyTreatment of allergic rhinitis with desloratadine: results of a multinational observational study in the middle East gulf regionStrategies for the management of intermittent allergic rhinitis: an Australian studySafety evaluation of desloratadine in allergic rhinitis.Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK.MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.Current controversies and challenges in allergic rhinitis management.Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.Efficacy and safety of the probiotic Lactobacillus paracasei LP-33 in allergic rhinitis: a double-blind, randomized, placebo-controlled trial (GA2LEN Study).Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis.Impact of allergic rhinitis symptoms on quality of life in primary care.Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of A
P2860
Q28282236-5C99C7CE-AD38-4566-83FA-A37D72B12E3AQ28355722-751C3781-11FA-4E98-8D18-E928CF5A7960Q30583273-14856EB6-E054-4742-AE59-4997B1623EFFQ35050198-D4210D98-A7ED-4337-9F0E-9E715FAC4552Q36211005-F8954618-F59A-4550-9A82-EF8090F83CD8Q36638677-E4AE2378-18C2-469B-B926-23457FAAB0A5Q36834691-0B3DCD39-59DD-46E0-9FC3-A3113C69C6E3Q37333075-FE0DC465-19DE-40FE-8116-74CA51AF7FFAQ38097964-72CC9886-620B-4D73-B7E4-3FE3D177FA87Q38401392-B942BA9E-4723-4025-97F4-BB2C50D9353FQ38543189-1B2CA7CF-F119-46C8-8B5D-6CD7F09CE13AQ38577949-D6A68A21-E906-42AD-91C3-EE81069C315EQ38721025-BB9D21C2-DF63-4AE2-AA25-4F1700D62DBEQ42736324-F6CAB255-4A66-4A20-8DE8-EC29E199F99FQ44167428-9E3203F3-8B30-479A-983A-0941D8BDE510Q44794327-904F6E1B-A6D4-4F85-BFBC-5B1E97DBA012Q47977560-8D5887D6-D071-43C9-8DF2-09E18B75DAE9Q48209846-567E7493-0E1B-403A-95BA-21B18C8A18E5Q56971253-C2D4D018-8B88-42F7-AC70-F14FC747D37C
P2860
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Efficacy of desloratadine in intermittent allergic rhinitis: a GA
@nl
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
@en
type
label
Efficacy of desloratadine in intermittent allergic rhinitis: a GA
@nl
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
@en
prefLabel
Efficacy of desloratadine in intermittent allergic rhinitis: a GA
@nl
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
@en
P2093
P50
P1433
P1476
Efficacy of desloratadine in intermittent allergic rhinitis: a GA(2)LEN study.
@en
P2093
ACCEPT-1 study group
J Bousquet
P Van Cauwenberge
W J Fokkens
P304
P356
10.1111/J.1398-9995.2009.02115.X
P577
2009-07-14T00:00:00Z